Company-Diagnostics Inc Stock News

Co-Diagnostics (NASDAQ:CODX) Inc announced that it has signed agreements to acquire Idaho Molecular Inc and Advance Conceptions Inc for the development of its upcoming at-home/point-of-care diagnost

With the omicron variant presenting uncertainties regarding how governments will react, here are some stocks to buy to counter that risk. The post 7 Stocks to Buy to Hedge Against Omicron Variant Risk

Pfizer Inc. (NYSE:PFE) with the stream of 1.34% also noticed, India Co-Diagnostics, Inc. (NASDAQ:CODX) encountered a rapid change of -1.97% in the last hour of Fridays trading session. Pfizer Inc. The post Do the Stock Experienced Heavy Trading? Pfizer Inc. (NYSE:PFE), Co-Diagnostics, Inc. (NASDAQ:CODX) appeared first on Stocks Equity .

Co-Diagnostics (NASDAQ:CODX) Inc said it has partnered with TiiCKER—a consumer shareholder loyalty platform—to increase its connection to retail investors.  The Salt Lake City-based company has

Select Medical (SEM) is focused on making strategic acquisitions to boost its business through inorganic growth.

Co-Diagnostics (NASDAQ:CODX) and Asensus Surgical (NYSE:ASXC) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation. Insider and Institutional Ownership 25.6% of Co-Diagnostics shares are held by institutional investors. Comparatively, 24.8% of []

Price T Rowe Associates Inc. MD cut its stake in Co-Diagnostics, Inc. (NASDAQ:CODX) by 16.7% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 39,600 shares of the companys stock after selling 7,929 shares during the period. Price T Rowe Associates []

Acadia Healthcare Company (ACHC) expects to take on Orlando Health South Seminole Hospital's management responsibilities of the behavioral health program.

Charles Schwab Investment Management Inc. decreased its holdings in Co-Diagnostics, Inc. (NASDAQ:CODX) by 51.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 54,044 shares of the companys stock after selling 57,263 shares during the period. Charles Schwab Investment Management Inc. owned []

HC Wainwright reissued their buy rating on shares of Co-Diagnostics (NASDAQ:CODX) in a report published on Tuesday morning, TipRanks reports. HC Wainwright currently has a $15.00 price objective on the stock. Several other research analysts have also recently weighed in on CODX. Zacks Investment Research upgraded Co-Diagnostics from a hold rating to a buy rating []

HC Wainwright restated their buy rating on shares of Co-Diagnostics (NASDAQ:CODX) in a research report sent to investors on Tuesday, TipRanks reports. They currently have a $15.00 price objective on the stock. Other equities research analysts also recently issued research reports about the company. Litchfield Hills Research restated a buy rating on shares of Co-Diagnostics []

Co-Diagnostics (NASDAQ:CODX) and Asensus Surgical (NYSE:ASXC) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations. Analyst Ratings This is a breakdown of current ratings for Co-Diagnostics and Asensus Surgical, as reported []

Acadia Healthcare's (ACHC) buyouts are helping the company to add facilities, beds and hospitals to its network and contributing to its top line.